REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/13/2025
Back to search
Official data from USPTO
AMERIDRUG DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AMERIDRUG DIAGNOSTICS
ST13
US500000078608287Class
5
Filing
78608287
Registration
3103578
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/14/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
04/13/2005
Registration date
06/13/2006
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/19/2019
Last transaction
06/14/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/11/2004
First use in commerce
02/11/2004
Drawing code
4
Owner type
01
Owner location
Loveland, CO
Examiner
SPRUILL, DARRYL
Law office
M30
Current location
POST REGISTRATION
Holders and representatives
Holders
Huff, Blane
Huff, Blane
Representatives
Robert Croteau Attorney at Law
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug testing supplies: namely-disposable cups and urine analysis strips for determining drug usage
Publications
History of USPTO decisions and trademark events.
31 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/19/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/19/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/19/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/28/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/25/2016
FAXX
FAX RECEIVED
05/20/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
05/19/2016
ES7R
TEAS SECTION 7 REQUEST RECEIVED
05/19/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/13/2015
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/29/2011
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/28/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/28/2011
ES8R
TEAS SECTION 8 RECEIVED
08/23/2011
CORV
REVIEW OF CORRESPONDENCE COMPLETE
06/08/2009
FAXX
FAX RECEIVED
04/28/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/12/2007
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/12/2007
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/12/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2006
PUBO
PUBLISHED FOR OPPOSITION
03/21/2006
NPUB
NOTICE OF PUBLICATION
03/01/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/04/2006
ALIE
ASSIGNED TO LIE
02/04/2006
CNEA
EXAMINERS AMENDMENT MAILED
01/24/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2006
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/23/2006
CNRT
NON-FINAL ACTION MAILED
11/14/2005
CNRT
NON-FINAL ACTION WRITTEN
11/10/2005
DOCK
ASSIGNED TO EXAMINER
11/09/2005
NWAP
NEW APPLICATION ENTERED
04/21/2005
Continuous trademark protection
Get notified about every new filing that threatens AMERIDRUG DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.